StockNews.com Begins Coverage on Pulmatrix (NASDAQ:PULM)

StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM – Free Report) in a research report report published on Tuesday. The brokerage issued a hold rating on the biotechnology company’s stock. Pulmatrix Price Performance NASDAQ PULM opened at $1.88 on Tuesday. The stock has a market capitalization of $6.86 million, a PE ratio of -0.80 and […]

Leave a Reply

Your email address will not be published.

Previous post Genocea Biosciences (NASDAQ:GNCA) Now Covered by Analysts at StockNews.com
Next post Rocky Mountain Chocolate Factory (NASDAQ:RMCF) Now Covered by StockNews.com